您的位置: 首页 > 农业专利 > 详情页

Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases
专利权人:
ALNYLAM PHARMACEUTICALS INC.
发明人:
RAJEEV KALLANTHOTTATHIL G.,ZIMMERMANN TRACY,MANOHARAN MUTHIAH,MAIER MARTIN,KUCHIMANCHI SATYANARAYANA,CHARISSE KLAUS
申请号:
NZ62433612
公开号:
NZ624336A
申请日:
2012.11.16
申请国别(地区):
NZ
年份:
2016
代理人:
摘要:
Disclosed are double stranded RNAi agents comprising a sense strand complementary to an antisense strand, wherein said antisense strand comprises a sequence that is complementary to nucleotides 504 to 526 of the transthyretin (TTR) gene (SEQ ID NO:1), wherein the sense strand is 21 nucleotides in length and 5 the antisense strand is 23 nucleotides in length and wherein said RNAi agents comprise one or more motifs of three identical modifications on three consecutive nucleotides in one or both strands, including one such motif at or near the cleavage site of the agents. The invention also provides for the use of said RNAi agents for the manufacture of a medicament for treating a TTR-associated disease in a subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充